210 related articles for article (PubMed ID: 8417805)
1. Three new monoclonal antibodies that define a unique antigen associated with prolymphocytic leukemia/non-Hodgkin's lymphoma and are effectively internalized after binding to the cell surface antigen.
Okazaki M; Luo Y; Han T; Yoshida M; Seon BK
Blood; 1993 Jan; 81(1):84-94. PubMed ID: 8417805
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody SN10 which shows a highly selective reactivity with human B leukemia-lymphoma and is effectively internalized into cells.
Takeuchi T; Barcos MP; Seon BK
Cancer Res; 1991 Jun; 51(11):2985-93. PubMed ID: 1709587
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies against the chronic lymphatic leukemia antigen cCLLa: characterization and reactivity.
Faguet GB; Agee JF
Blood; 1987 Aug; 70(2):437-43. PubMed ID: 2440501
[TBL] [Abstract][Full Text] [Related]
4. Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b).
Zomas AP; Matutes E; Morilla R; Owusu-Ankomah K; Seon BK; Catovsky D
Leukemia; 1996 Dec; 10(12):1966-70. PubMed ID: 8946938
[TBL] [Abstract][Full Text] [Related]
5. Production of anti-B monoclonal antibodies (DBB.42, DBA.44, DNA.7, and DND.53) reactive on paraffin-embedded tissues with a new B-lymphoma cell line grafted into athymic nude mice.
al Saati T; Caspar S; Brousset P; Chittal S; Caverivière P; Hounieu H; Dastugue N; Idoipe JB; Icart J; Mazerolles C
Blood; 1989 Nov; 74(7):2476-85. PubMed ID: 2679917
[TBL] [Abstract][Full Text] [Related]
6. Distinct human leukemia-associated cell surface glycoprotein GP160 defined by monoclonal antibody SN6.
Haruta Y; Seon BK
Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7898-902. PubMed ID: 3464004
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
[TBL] [Abstract][Full Text] [Related]
8. Expression of the CD11c antigen in B-cell chronic lymphoproliferative disorders.
Marotta G; Raspadori D; Sestigiani C; Scalia G; Bigazzi C; Lauria F
Leuk Lymphoma; 2000 Mar; 37(1-2):145-9. PubMed ID: 10721778
[TBL] [Abstract][Full Text] [Related]
9. An antigen common to chronic lymphocytic and hairy cell leukemia cells not shared by normal lymphocytes or by other leukemic cells.
Agee JF; Garver FA; Faguet GB
Blood; 1986 Jul; 68(1):62-8. PubMed ID: 2941085
[TBL] [Abstract][Full Text] [Related]
10. A new small cell lung cancer (SCLC)-specific marker discovered through antigenic subtraction of neuroblastoma cells.
Krueger P; Nitz C; Foster R; MacDonald C; Gelber O; Lalehzadeh G; Goodson R; Winter J; Gelber C
Cancer Immunol Immunother; 2003 Jun; 52(6):367-77. PubMed ID: 12669243
[TBL] [Abstract][Full Text] [Related]
11. Expression of Ki-67 nuclear antigen in B and T cell lymphoproliferative disorders.
de Melo N; Matutes E; Cordone I; Morilla R; Catovksy D
J Clin Pathol; 1992 Aug; 45(8):660-3. PubMed ID: 1401173
[TBL] [Abstract][Full Text] [Related]
12. Common chronic lymphatic leukemia antigen (cCLLa); distribution, fate and clinical applications.
Faguet GB
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):305-10. PubMed ID: 2464791
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies in the treatment of chronic lymphoid leukemias.
Robak T
Leuk Lymphoma; 2004 Feb; 45(2):205-19. PubMed ID: 15101704
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies against Epstein-Barr virus transformed B lymphocytes from a CLL patient.
Guha AK; Ghose T; Luner SJ; Nolido-Cruz H; Uniyal S; Rajaraman R; Fernandez LA; Lee SS; Lee CL
Hybridoma; 1990 Apr; 9(2):119-32. PubMed ID: 2161403
[TBL] [Abstract][Full Text] [Related]
15. Idiotypic cross-reactivity of immunoglobulins expressed in Waldenström's macroglobulinemia, chronic lymphocytic leukemia, and mantle zone lymphocytes of secondary B-cell follicles.
Axelrod O; Silverman GJ; Dev V; Kyle R; Carson DA; Kipps TJ
Blood; 1991 Apr; 77(7):1484-90. PubMed ID: 1901234
[TBL] [Abstract][Full Text] [Related]
16. New monoclonal antibodies SN3, SN3a, and SN3b directed to sialic acid of glycoprotein on human non-T leukemia cells.
Fukukawa T; Matsuzaki H; Haruta Y; Hara H; Seon BK
Exp Hematol; 1986 Oct; 14(9):850-5. PubMed ID: 3489635
[TBL] [Abstract][Full Text] [Related]
17. Levels of expression of CD19 and CD20 in chronic B cell leukaemias.
Ginaldi L; De Martinis M; Matutes E; Farahat N; Morilla R; Catovsky D
J Clin Pathol; 1998 May; 51(5):364-9. PubMed ID: 9708202
[TBL] [Abstract][Full Text] [Related]
18. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
20. RAB-1: a new monoclonal antibody to leukemic hairy cells.
Berrebi A; Eshhar Z; Linder S; Guedj L; Avraham H
Leuk Res; 1986; 10(9):1071-8. PubMed ID: 3531732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]